TWO DOSES OF GW433908/RITONAVIR GIVEN WITH ABACAVIR/LAMIVUDINE COMBO

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purposes of this study are: 1) to find out if taking fosamprenavir with 100 mg RTV plus ABC/3TC FDC is as effective as taking fosamprenavir with 200 mg RTV plus ABC/3TC FDC; 2) to measure T-cells; 3) to collect information on the safety of the two treatments; 4) to assess the physical signs and symptoms of lipodystrophy syndrome; 5) to measure the amounts of amprenavir in blood at certain time points to find out if medication has been taken correctly.